Navigation Links
FAST RED Chromogen (SIGNET) from Covance Research Products, Inc

ProductsFAST RED Chromogen (SIGNET) from Covance Research Products, Inc
Company Covance Research Products, Inc
Item FAST RED Chromogen (SIGNET)
Price $89.00
Description Signets FAST RED Chromogen System consists of FAST RED chromogen tablets and substrate buffer. FAST RED reacts in the presence of alkaline phosphatase to produce red staining with minimal background noise. The FAST RED tablets provides enough material for 1000 tests.
Info Covance Research Products, IncCovance Research Products, Inc
P.O. Box 7200
Denver, Pennsylvania 17517

Customer Service:
800-345-4114 (Toll Free)
717-336-4921

Fax Number:
717-336-5344

Web Site: http://www.crpinc.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. FAST RED Chromogen System (SIGNET) from Covance Research Products, Inc
2. NBT/BCIP Chromogen System (SIGNET) from Covance Research Products, Inc
3. NBT/BCIP Chromogen System (SIGNET) from Covance Research Products, Inc
4. Mouse Immunoglobulin Chromogenic Kit, WesternBreeze Chromogenic from Invitrogen
5. bacterial endotoxin Chromogenic Assay Kit from Cell Sciences
6. Capillary Action Water Wash, 1L (SIGNET) from Covance Research Products, Inc
7. beta-Amyloid 1-40 ELISA Kit (SIGNET) from Covance Research Products, Inc
8. Ultrastreptavidin (USA) Horseradish peroxidase (HRP) 50 Test, Murine, AEC Detection Kit (SIGNET) from Covance Research Products, Inc
9. Ultrastreptavidin (USA) Horseradish peroxidase (HRP) 50 Test, Multi-Species, AEC Detection Kit (SIGNET) from Covance Research Products, Inc
10. Ultrastreptavidin (USA) Horseradish peroxidase (HRP) 50 Test, Murine, DAB Detection Kit (SIGNET) from Covance Research Products, Inc
11. Ultrastreptavidin (USA) Horseradish peroxidase (HRP) 1000 Test, Multi-Species, DAB Detection Kit (SIGNET) from Covance Research Products, Inc
For microscopy...
... cDNA Synthesis and Labeling Kit generates labeled ... First unmodified cDNA is made via a ... an Oligo(dT) primer. Unlike other methods, there ... the reverse transcription reaction. This unmodified cDNA ...
... high quality microarray scanner based on patented confocal ... spatial resolution. The DNAscope LM is unique ... scanner that is upgradeable to a total of ... Includes control module (computer), monitor, and ...
AC input: 50-60 Hz 115-120 V...
Biology Products:
(Date:10/17/2014)... of Copenhagen have shown for the first time how ... fibrosis patients, giving them the opportunity to get tremendous ... , The study also discovered the bacterial growth in ... halted or slowed down by the immune cells. The ... and helped "suffocate" the bacteria, forcing the bacteria to ...
(Date:10/16/2014)... researchers have challenged conventional thinking on how the bowel ... mechanism for how bowel cancer starts. , The researchers ... and regenerating the ,crypts, that are a feature of ... involved in bowel cancer development, a controversial finding as ... , Using 3D imaging technologies, Dr Chin Wee Tan ...
(Date:10/15/2014)... , Oct. 15, 2014 Sandata ... for home and community-based care, today announced it ... implementing Sandata,s Santrax® Electronic Visit Verification™ Solution (EVV™) ... is a home health company founded in 1996 ... . The study details ...
Breaking Biology News(10 mins):Scientists opens black box on bacterial growth in cystic fibrosis lung infection 2Cryptic clues drive new theory of bowel cancer development 2Sandata Announces Case Study with Quality Care Services, Inc. 2
... SALT LAKE CITY A single organ may contain more ... that complicates prospects for using the versatile cells to replace ... new study from the laboratory of geneticist Mario Capecchi, the ... online issue of the journal Nature Genetics, Capecchi and geneticist ...
... challenges is to understand the design principles and origins ... on the evolutionary origins of the brain and how ... humans. The research suggests that it is not ... during evolution, increasingly sophisticated molecular processing of nerve impulses ...
... Communication,Intelligence Corporation (the "Company") (OTC Bulletin Board: ... business process,automation in the financial industry and the ... it has closed a financing, on,June 5, 2008, ... As part of the financing, the Company ...
Cached Biology News:Caution on stem cell therapy 2Caution on stem cell therapy 3Caution on stem cell therapy 4Origins of the brain 2Origins of the brain 3Communication Intelligence Corporation Closes $3.6 Million Financing 2Communication Intelligence Corporation Closes $3.6 Million Financing 3Communication Intelligence Corporation Closes $3.6 Million Financing 4
(Date:10/22/2014)... , Oct. 22, 2014   Synthetic Biologics, ... novel pathogen-specific therapies for serious infections and diseases, announced ... issued a Notice of Allowance for a composition of ... C. difficile program, SYN-004. This is Synthetic ... in the U.S. and adds to the Company,s extensive ...
(Date:10/22/2014)... -- Nuvilex, Inc. (OTCQB: NVLX) – According to the ... living with diabetes, with  that number expected to grow ... for diabetes treatments is approximately $500 billion.  ... pancreatic cancer.  Pancreatic cancer is the fourth most common ... the United States , and according to a ...
(Date:10/22/2014)... and HONG KONG , Oct. 22, ... therapeutics enterprise, announced today that rare disease expert ... vice president, research. Dr. McKew brings more than two ... positions at the National Institutes of Health, Wyeth Research ... Wyeth). Dr. McKew will lead aTyr,s efforts to expand and ...
(Date:10/20/2014)... Oct. 20, 2014 Mapp Biopharmaceutical,s valiant ... antibody therapeutic to fight the Ebola outbreak will ... time-consuming the production of pharmaceuticals can be, according ... said that while some may be taken aback ... those with industry knowledge are well aware of ...
Breaking Biology Technology:Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 3